Tinnitus Patient Preferences Survey | MicrobiomeTrials← Back to trialsNCT06782308
Tinnitus Patient Preferences Survey
CompletedOBSERVATIONAL
Trial Details
Start: 2025-01-13Est. Completion: 2026-09-03
Enrollment target: 1,000 participants Locations- Neurosoft Bielectronics US Inc., New York, New York, United States
Other microbiome trials you might be interested in
Hearing Loss, ConductiveHearing Loss, MixedDeafness, Unilateral
The primary objective of the study is to evaluate OID hearing intervention on cognition among patients who could vs. do …
Tampa, United StatesEst. completion Dec 2027
Post-COVID-19 ConditionUlcerative ColitisCrohn DiseaseCalciphylaxisFrostbiteAcute COVID-19Pyoderma GangrenosumPterygium
Hypospadias
Head Trauma
Pneumatosis Intestinalis
Ischemic Bowel
Raynaud Syndrome
Malignant Otitis Externa
Nonarteritic Anterior Ischemic Optic Neuropathy
Central Retinal Vein Occlusion
Femoral Head Necrosis
Invasive Fungal Infection
Chronic Anal Fissure
Vasculitic Ulcer
Graft-vs-Host Disease
Decubitus Ulcer
Greater Trochanteric Pain Syndrome
Rectovaginal Fistula
Pouchitis
Tinnitus
Clostridium Enterocolitis
Branch Retinal Artery Occlusion
Axonotmesis
Multiple Sclerosis
Inclusion Body Myositis
Epidermolysis Bullosa (EB)
Osteonecrosis
Ulcer Ischemic
Avascular Necrosis of Bone
Prosthesis Related Infections
Facial Filler Injections
Cystitis Chronic
Ligament Injury
Anastomosis, Leaking
Cartilage Injury
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., c…
Multiple LocationsEst. completion Dec 2035